Sailing Through the Storm: The Role of Integration Therapy in Healing from Psychedelic "Bad Trips"
The resurgence of interest in psychedelic substances for therapeutic purposes has brought to light not just their potential benefits but also the challenges they can present. One of the most distressing experiences associated with psychedelics is what is commonly known as a “bad trip.” These intense, often overwhelming experiences can leave individuals feeling confused, scared, and even traumatized. Integration therapy has emerged as a crucial process for helping individuals navigate and heal from these difficult encounters.
Psychedelic medicine is on its way. But it’s not ‘doing shrooms with your shrink’. Here’s what you need to know
Many people in Australia, including psychiatrists, were surprised when earlier this year the medicines regulator down-scheduled MDMA, known colloquially as ecstasy, and psilocybin, from magic mushrooms.
This means that under certain circumstances from July 1, authorised psychiatrists will be able to prescribe MDMA to treat post-traumatic stress disorder and psilocybin to treat depression that has not responded to other treatments. Patients must also undergo psychotherapy (talking therapy).
It all sounds very certain but it’s not really.